Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
European Journal of Cancer & Clinical Oncology
|
July 1, 1981
5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling
J H Mulder, T Smink, L M van Putten
Cancer Treatment Reports
|
April 1, 1976
Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labeled cell inoculation
J de Ruiter, T Smink, L M van Putten
European Journal of Cancer
|
October 1, 1977
Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy
J H Mulder, T Smink, L M Van Putten
European Journal of Cancer & Clinical Oncology
|
January 1, 1983
Tumor homogeneity largely determines the growth of human tumour xenografts in two systems
M B Edelstein, T Smink, L M van Putten
Behring Institute Mitteilungen
|
May 1, 1984
Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents
M B Edelstein, T Smink, L M van Putten
European Journal of Cancer
|
October 1, 1972
An attempt at selective chemotherapy of hypoxic cells: triethylenemelamine and irradiation of a C3H mouse mammary tumour
I F Tannock, N Marshall, L M van Putten
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Effectiveness of P-aminobenzoyl-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cells
P Lelieveld, R J Middeldorp, L M van Putten
European Journal of Cancer
|
April 1, 1979
Lack of vincristine--cyclophosphamide potentiation in different experimental tumour lines
J H Mulder, P Lelieveld, L M van Putten
European Journal of Cancer
|
May 1, 1971
Response of a poorly reoxygenating mouse osteosarcoma to x-rays and fast neutrons
L M van Putten, P Lelieveld, J J Broerse
European Journal of Cancer
|
February 1, 1976
Synchronization in tumour chemotherapy
L M Van Putten, H J Keizer, J H Mulder
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
European Journal of Cancer & Clinical Oncology
|
July 1, 1981
5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling
J H Mulder, T Smink, L M van Putten
Cancer Treatment Reports
|
April 1, 1976
Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labeled cell inoculation
J de Ruiter, T Smink, L M van Putten
European Journal of Cancer
|
October 1, 1977
Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy
J H Mulder, T Smink, L M Van Putten
European Journal of Cancer & Clinical Oncology
|
January 1, 1983
Tumor homogeneity largely determines the growth of human tumour xenografts in two systems
M B Edelstein, T Smink, L M van Putten
Behring Institute Mitteilungen
|
May 1, 1984
Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents
M B Edelstein, T Smink, L M van Putten
European Journal of Cancer
|
October 1, 1972
An attempt at selective chemotherapy of hypoxic cells: triethylenemelamine and irradiation of a C3H mouse mammary tumour
I F Tannock, N Marshall, L M van Putten
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Effectiveness of P-aminobenzoyl-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cells
P Lelieveld, R J Middeldorp, L M van Putten
European Journal of Cancer
|
April 1, 1979
Lack of vincristine--cyclophosphamide potentiation in different experimental tumour lines
J H Mulder, P Lelieveld, L M van Putten
European Journal of Cancer
|
May 1, 1971
Response of a poorly reoxygenating mouse osteosarcoma to x-rays and fast neutrons
L M van Putten, P Lelieveld, J J Broerse
European Journal of Cancer
|
February 1, 1976
Synchronization in tumour chemotherapy
L M Van Putten, H J Keizer, J H Mulder
Page
of 8